APPLICATION
NDA215092
TYPE
NDA
ORIGINAL APPROVAL
2022-09-22
LATEST ACTION
2022-09-22
ROUTE
OPHTHALMIC
DOSAGE FORM
SOLUTION
MARKETING STATUS
Prescription
Products
OMLONTI · ReferencePrescription
OMIDENEPAG ISOPROPYL 0.002% · SOLUTION · OPHTHALMIC
Approval history
2022-09-22UNKNOWN · Supplement 1 · standardAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.